恶性腹水的内科处理进展  

Advances of medical management in malignant ascites

作　　者：何义富[1] 罗会芹[1] 胡冰[1] 

机构地区：[1]安徽医科大学附属省立医院肿瘤科,合肥230001

出　　处：《临床肿瘤学杂志》2013年第5期472-474,共3页Chinese Clinical Oncology

基　　金：安徽省自然科学基金资助项目(070413256X);2010年安徽省卫生厅医学科研课题(2010B001)

摘　　要：恶性腹水是指恶性肿瘤导致的腹腔积液的异常增多,可以引起腹胀、恶心、呕吐、厌食、呼吸困难以及肢体水肿,继而引起患者的生活质量下降。目前,不同的治疗措施尚缺乏很好的循证医学证据以及缺乏公认的处理指南。对于临床医师的挑战是如何最佳处理恶性腹水,以达到最佳的治疗效果。本文现对恶性腹水的内科处理方法做一综述。Malignant ascites （MA） are the cancer-associated accumulation of fluids in the peritoneal cavity. Symptoms in- clude abdominal distention, nausea, vomiting, anorexia, dyspnea and limbs oedemas, producing a significant reduction in the patients＇ quality of life. Currently, none of the different options has been subjected to evidence-based clinical trials and there are no accepted guidelines for the management of MA. The challenge for clinicians is to know how to best manage the symptoms of MA patients for opti- mal outcomes. The purpose of this article is to discuss critically the medical management of MA.

关 键 词：恶性腹水 生活质量 内科处理 

分 类 号：R730.6[医药卫生—肿瘤]